P15. Crizotinib in metastatic ALK-positive lung cancer—results from clinical practice in Slovakia

BACKGROUND: Crizotinib was approved and authorized for use in the European Union in October 2012. Since then crizotinib has been available in Slovakia for treatment of advanced metastatic non-small cell lung cancer (NSCLC) after failure of standard chemotherapy only, based on the wording of the ther...

全面介紹

Na minha lista:
書目詳細資料
發表在:Transl Lung Cancer Res
Main Authors: Berzinec, Peter, Kasan, Peter, Plank, Lukas, Andrasina, Igor, Godal, Robert, Mazal, Juraj, Cipkova, Andrea, Denkova, Lucia, Chowaniecova, Gabriela, Kuliskova, Iveta
格式: Artigo
語言:Inglês
出版: Pioneer Bioscience Publishing Company 2014
主題:
CELCC 2014 Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367737/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB027
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍